Co-authored Publications

Lu, X., He, Y., Johnston, R.L., Nanayakkara, D., Sankarasubramanian, S., Lopez, J.A., Friedlander, M., Kalimutho, M., Hooper, J.D., Raninga, P.V., Khanna, K.K. (2022). CBL0137 impairs homologous recombination repair and sensitizes high-grade serous ovarian carcinoma to PARP inhibitors. Journal of Experimental & Clinical Cancer Research, 21; 41(1):355. Doi: 10.1186/s13046-022-02570-4

Sinha, D., Nag, P., Nanayakkara, D., Duijf, P.H.G., Burgess, A., Raninga, P., Smits, V.A.J., Bain, A.L., Subramanian, G., Wall, M., Finnie, J.W., Kalimutho, M., Khanna, K.K.(2020) Cep55 overexpression promotes genomic instability and tumorigenesis in mice. Communication Biology 3(1), 593. Doi: 10.1038/s42003-020-01304-6

Duijf, P.H.G., Nanayakkara, D., Nones, K, Srihari, S., Kalimutho, M., Khanna, K.K. (2019) Mechanisms of genomic instability in breast cancer. Trends in Molecular Medicine, 595-611. Doi: 10.1016/j.molmed.2019.04.004

Yang, R-M., Nanayakkara,D., Kalimutho, M., Mitra.P., Khanna,K.K., Dray, E., Gonda, T.J. (2019) MYB regulates the DNA damage response and components of the homology-directed repair pathway in human estrogen receptor-positive breast cancer cells. Oncogene 38, 5239-5249. Doi: 10.1038/s41388-019-0789-3

Bridges, C.R, Premarathne, S., Tan, M., Nanayakkara, D.M., Bellette, B., Zencak, D., Domingo, D., Gecz, J., Murtaza,M., Jolly,L., Wood, S.A. (2017) USP9X deubiquitylating enzyme maintains RAPTOR proteins levels, mTORC1 signalling and proliferation in neural progenitors. Scientific Reports, 7:391. Doi: 10.1038/s41598-017-00149-0

Nanayakkara, D.M., Nguyen, M., Wood, S.A. (2016) Deubiquitylating enzyme, USP9X, promotes proliferation of head and neck cancer cell lines. Cell Proliferation, 49(4):494-502. Doi: 10.1111/cpr.12273

Nanayakkara, D.M., Rajapakse, R.P.V.J., Wickramasinghe, S., Kularatne, S.A.M. (2013) Serological evidence for exposure of dogs to Rickettsia conorii, Rickettsia typhi, and Orientia tsutsugamushi in Sri Lanka. Vector Borne and Zoonotic Diseases, 13(8):545-9. Doi: 10.1089/vbz.2012.1049

Kularatne, S.A.M., Weerakoon, K.G.A.D., Rajapakse, R.P.V.J., Madagedara, S.C., Nanayakkara, D., Premaratna,R. (2012) A case series of spotted fever rickettsiosis with neurological manifestations in Sri Lanka. International Journal of Infectious Diseases 16(7). Doi: 10.1016/j.ijid.2012.02.018

Policy Briefs

Nanayakkara, D., Karthikeya, S., Qiao, E. (2026). (Cth) Exempt new antimicrobials from registration and HTA fees. FORE Good. https://www.foregood.org.au/post/cth-exempt-new-antimicrobials-from-registration-and-hta-fees

Nanayakkara, D., Grace, E.B., Luu, J. (2026). (Cth) Exempt orphan drugs from all PBAC submission fees. FORE Good. https://www.foregood.org.au/post/cth-exempt-orphan-drugs-from-all-pbac-submission-fees

Online Articles

Nanayakkara, D. (2026). 450,000 Australians were expected to benefit from cheaper Mounjaro. What happened? Medium. https://medium.com/@ransin25/450-000-australians-were-expected-to-benefit-from-cheaper-mounjaro-what-happened-9933af864cce?sharedUserId=ransin25

Let's Create Something Together

I'd love to hear about your project. Book a free discovery call.

Get in Touch